HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ATP6V0A4
ATPase H+ transporting V0 subunit a4
Chromosome 7 Β· 7q34
NCBI Gene: 50617Ensembl: ENSG00000105929.17HGNC: HGNC:866UniProt: Q9HBG4
64PubMed Papers
21Diseases
0Drugs
85Pathogenic Variants
FUNCTIONAL ROLE
Transporter
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
ATPase bindingbrush border membraneapical plasma membraneossificationrenal tubular acidosis, distal, 3, with or without sensorineural hearing lossautosomal recessive distal renal tubular acidosisgenetic disorderdistal renal tubular acidosis
✦AI Summary

ATP6V0A4 encodes the a4 subunit of vacuolar H+-ATPase (V-ATPase), a proton pump essential for cellular acidification 1. As a V0 domain component, ATP6V0A4 mediates ATP-dependent proton translocation across membranes, maintaining intracellular compartment pH and, when targeted to the apical plasma membrane of kidney collecting duct cells, enabling urinary acidification 1. In renal type A intercalated cells, ATP6V0A4 drives active acid secretion critical for distal urinary acidification and systemic acid-base homeostasis 2. Loss-of-function mutations in ATP6V0A4 impair proton transport efficacy, causing distal renal tubular acidosis (dRTA) characterized by inability to acidify urine below pH 5.5, often accompanied by sensorineural hearing loss 23. Conversely, a gain-of-function p.V512L mutation was recently identified that enhances V-ATPase activity, producing metabolic alkalosis with acidic urineβ€”expanding ATP6V0A4's phenotypic spectrum 4. Beyond renal function, ATP6V0A4 participates in phagosome maturation, endosomal trafficking, and lysosomal acidification in immune cells 5. Emerging evidence suggests ATP6V0A4 dysregulation may influence cancer progression and immunotherapy responsiveness 6. Untreated dRTA from ATP6V0A4 deficiency causes rickets, nephrolithiasis, and chr7 kidney disease progression 2.

Sources cited
1
dRTA pathophysiology, ATP6V0A4 mutations causing dRTA, clinical complications of untreated dRTA
PMID: 37016093
2
ATP6V0A4 encodes V-ATPase a4 subunit mediating H+ transport; gain-of-function mutation phenotype and mechanism
PMID: 40299568
3
ATP6V0A4 role in phagosome maturation, endosomal trafficking, and lysosomal acidification
PMID: 38873931
4
V-ATPase structure and function; ATP6V0A4 and ATP6V1B1 mutations in dRTA; kidney-specific V-ATPase roles
PMID: 15383652
5
ATP6V0A4 loss-of-function mutations cause primary dRTA with metabolic acidosis and renal complications
PMID: 37730230
6
ATP6V0A4 dysregulation linked to cancer progression and immunotherapy responsiveness
PMID: 40721755
Disease Associationsβ“˜21
renal tubular acidosis, distal, 3, with or without sensorineural hearing lossOpen Targets
0.79Strong
autosomal recessive distal renal tubular acidosisOpen Targets
0.65Moderate
genetic disorderOpen Targets
0.47Moderate
distal renal tubular acidosisOpen Targets
0.46Moderate
hearing lossOpen Targets
0.42Moderate
Sensorineural hearing impairmentOpen Targets
0.42Moderate
ovarian neoplasmOpen Targets
0.30Weak
ulcerative colitisOpen Targets
0.27Weak
sensorineural hearing lossOpen Targets
0.27Weak
Pancreatic pseudocystOpen Targets
0.27Weak
renal tubular acidosis, distal, 2, with progressive sensorineural hearing lossOpen Targets
0.27Weak
ocular hypotensionOpen Targets
0.26Weak
age-related hearing impairmentOpen Targets
0.22Weak
bladder neck obstructionOpen Targets
0.22Weak
keratoconusOpen Targets
0.10Weak
oral squamous cell carcinomaOpen Targets
0.07Suggestive
nonpapillary renal cell carcinomaOpen Targets
0.07Suggestive
neoplasmOpen Targets
0.07Suggestive
premature birthOpen Targets
0.06Suggestive
alcohol drinkingOpen Targets
0.06Suggestive
Renal tubular acidosis, distal, 3, with or without sensorineural hearing lossUniProt
Pathogenic Variants85
NM_020632.3(ATP6V0A4):c.16C>T (p.Arg6Ter)Pathogenic
not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|Renal tubulopathies
β˜…β˜…β˜†β˜†2026β†’ Residue 6
NM_020632.3(ATP6V0A4):c.2257C>T (p.Gln753Ter)Pathogenic
Autosomal recessive distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided
β˜…β˜…β˜†β˜†2026β†’ Residue 753
NM_020632.3(ATP6V0A4):c.1346G>A (p.Arg449His)Pathogenic
Autosomal recessive distal renal tubular acidosis|Distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 449
NM_020632.3(ATP6V0A4):c.1691+2dupPathogenic
Autosomal recessive distal renal tubular acidosis|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2025
NM_020632.3(ATP6V0A4):c.1231G>T (p.Asp411Tyr)Pathogenic
Autosomal recessive distal renal tubular acidosis|not provided|ATP6V0A4-related disorder|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2025β†’ Residue 411
NM_020632.3(ATP6V0A4):c.1572+2T>CLikely pathogenic
Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|not provided
β˜…β˜…β˜†β˜†2025
NM_020632.3(ATP6V0A4):c.707AGA[1] (p.Lys237del)Pathogenic
Sensorineural hearing loss disorder|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss|Renal tubulopathies
β˜…β˜…β˜†β˜†2025β†’ Residue 237
NM_020632.3(ATP6V0A4):c.2420G>A (p.Arg807Gln)Pathogenic
Autosomal recessive distal renal tubular acidosis|not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2025β†’ Residue 807
NM_020632.3(ATP6V0A4):c.1180+1delPathogenic
not provided|Autosomal recessive distal renal tubular acidosis
β˜…β˜…β˜†β˜†2025
NM_020632.3(ATP6V0A4):c.1185del (p.Tyr396fs)Pathogenic
not provided
β˜…β˜…β˜†β˜†2025β†’ Residue 396
NM_020632.3(ATP6V0A4):c.1345C>T (p.Arg449Cys)Pathogenic
not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 449
NM_020632.3(ATP6V0A4):c.2419C>T (p.Arg807Ter)Pathogenic
not provided|Autosomal recessive distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 807
NM_020632.3(ATP6V0A4):c.977G>A (p.Trp326Ter)Pathogenic
Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 326
NM_020632.3(ATP6V0A4):c.1107del (p.Asn370fs)Pathogenic
not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 370
NM_020632.3(ATP6V0A4):c.2227C>T (p.Arg743Trp)Likely pathogenic
ATP6V0A4-related disorder|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 743
NM_020632.3(ATP6V0A4):c.1478+2T>GPathogenic
not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024
NM_020632.3(ATP6V0A4):c.1572G>A (p.Pro524=)Pathogenic
not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 524
NM_020632.3(ATP6V0A4):c.1187dup (p.Tyr396Ter)Pathogenic
not provided|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024β†’ Residue 396
NM_020632.3(ATP6V0A4):c.292-1G>APathogenic
Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024
NM_020632.3(ATP6V0A4):c.2257+1G>APathogenic
Autosomal recessive distal renal tubular acidosis|Renal tubular acidosis, distal, 3, with or without sensorineural hearing loss
β˜…β˜…β˜†β˜†2024
View on ClinVar β†—
Related Genes
SLC4A1Protein interaction100%ATP6V1E2Protein interaction100%ATP6V0D2Protein interaction100%ATP12AProtein interaction100%ATP4AProtein interaction100%ATP5MC1Protein interaction100%
Tissue Expression6 tissues
Brain
100%
Lung
89%
Bone Marrow
33%
Ovary
22%
Liver
11%
Heart
0%
Gene Interaction Network
Click a node to explore
ATP6V0A4SLC4A1ATP6V1E2ATP6V0D2ATP12AATP4AATP5MC1
PROTEIN STRUCTURE
Preparing viewer…
PDB9DET Β· 3.00 Γ… Β· EM
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.92LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.76 [0.64–0.92]
RankingsWhere ATP6V0A4 stands among ~20K protein-coding genes
  • #7,238of 20,598
    Most Researched64
  • #881of 5,498
    Most Pathogenic Variants85 Β· top quartile
  • #8,382of 17,882
    Most Constrained (LOEUF)0.92
Genes detectedATP6V0A4
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
The pathophysiology of distal renal tubular acidosis.
PMID: 37016093
Nat Rev Nephrol Β· 2023
1.00
2
A gain-of-function mutation in ATP6V0A4 drives primary distal renal tubular alkalosis with enhanced V-ATPase activity.
PMID: 40299568
J Clin Invest Β· 2025
0.90
3
The different roles of V-ATPase a subunits in phagocytosis/endocytosis and autophagy.
PMID: 38873931
Autophagy Β· 2024
0.80
4
The presence of blastocyst within the uteri facilitates lumenal epithelium transformation for implantation via upregulating lysosome proteostasis activity.
PMID: 37584546
Autophagy Β· 2024
0.70
5
Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
PMID: 37848412
Signal Transduct Target Ther Β· 2023
0.60